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Spain1. Summary
Prefoldin is a cochaperone, present in all eukaryotes, that cooperateswith the cha-
peronin CCT. It is known mainly for its functional relevance in the cytoplasmic
folding of actin and tubulin monomers during cytoskeleton assembly. However,
both canonical and prefoldin-like subunits of this heterohexameric complex have
also been found in the nucleus, and are functionally connected with nuclear
processes in yeast and metazoa. Plant prefoldin has also been detected in the
nucleus and physically associated with a gene regulator. In this review, we
summarize the information available on the involvement of prefoldin in nuclear
phenomena, place special emphasis on gene transcription, and discuss the
possibility of a global coordination between gene regulation and cytoplasmic
dynamics mediated by prefoldin.2. Introduction
Misfolded proteins are detected shortly after their synthesis or after denaturation
events, and are targeted to refolding. A large set of molecular chaperones and
auxiliary factors are involved in this phenomenon (reviewed in [1]). Prefoldin
was first described as a cochaperone [2], capable of capturing unfolded polypep-
tides and transferring them to the ATP-dependent class II chaperonin CCT [3],
also known as c-cpn [4] or TriC [5].
Prefoldin is not present in Eubacteria, but it is present in Archaea [6], suggest-
ing that its ubiquitous presence in the eukaryotic kingdom is archaeal in origin [7].
Prefoldin is a heterohexameric complex. Whereas archaeal prefoldin is composed
of two identical a and four identical b subunits, canonical eukaryotic prefoldin is
composed of two different a and four different b subunits (figure 1a and table 1).
All eukaryotic organisms, from yeast to human, share this heterohexameric struc-
ture, indicating an early differentiation of the prefoldin subunits during the
evolution of eukaryotes. Eukaryotic prefoldin is evolutionarily conserved, because
human and plant subunits functionally complement yeast prefoldinmutants [8,9].
In all cases, two subunits of the a class form a dimer, onto which four subunits of
the beta class assemble and produce a jellyfish-like complex [10]. This complex
consists of a double b barrel assembly with six long tentacle-like coiled coils pro-
truding from it. The distal regions of these coiled coils expose hydrophobic
patches, required for the binding of misfolded proteins. This feature situates pre-
foldin among the set of chaperone factors that use clamp-like structural features
to grip substrate proteins [11].
Cytoskeleton components are the best-known targets of eukaryotic prefoldin
[8]. This captures unfolded actin, a- and b-tubulin cotranslationally, and remains
bound to the relatively unfoldedpolypeptides until their posttranslational delivery
to CCT [12] (figure 1b). Recognition of actin and tubulin by prefoldin involves
specific interactions between certain domains of the target proteins [13] and the
distal ends of different, but overlapping, sets of prefoldin subunits [14]. The so-
formed prefoldin-target binary complex is then able to interact with CCT. In this
ternary complex, prefoldin transfers actin to CCT following a handoff mechanism
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Figure 1. The prefoldin complex. (a) Canonical prefoldin is a heterohexameric complex composed of two a subunits (dark green), which play a central structural
role, and four b subunits (light green). (b) The best-characterized function of prefoldin is the cotranslational folding of proteins. Prefoldin binds unfolded poly-
peptides and transfers them to the ATP-dependent chaperon CCT prior to its assembly into high-order protein structures, such as microtubules and actin filaments.
(c) In addition to canonical complexes, which retain the structure of archaeal prefoldin, eukaryotes exhibit prefoldin-like complexes. In these, the two a and some of
the b canonical subunits are replaced with alternative polypeptides. Prefoldin-like complexes interact and functionally cooperate with other cochaperones such as
the R2TP complex ( purple).
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2[15]. Interestingly, the interaction between actin and eukaryotic
prefoldin maps inside the cavity formed by its six subunits,
whereas archaeal prefoldin stabilizes unfolded proteins by
interacting with the distal regions of the chaperone tentacles.
This suggests that the substrate interactionmechanismofprefol-
din has diverged through evolution and potentially reflects a
narrower range of substrates stabilized by prefoldin in eukar-
yotes [16]. Consistent with a role played by prefoldin in actin
and tubulin folding, the deletion of prefoldin-encoding genes
in Saccharomyces cerevisiae results in impaired cytoskeleton func-
tions [2]. These cytoskeletal defects of the prefoldinmutants areeven more marked in the absence of the phosducin-like protein
3, a factor that physically interacts with CCT and modulates its
chaperonin ATPase activity in vitro [17].
While none of the prefoldin subunits is essential for yeast
viability, the mutation of prefoldin genes or the depletion of
their products in Caenorhabditis elegans and Drosophila results in
embryonic lethality. In both cases, prefoldin-defective cells
show low tubulin levels and several cytoskeleton abnormalities
[18,19]. In the nematode, prefoldin depletion leads to a lower
microtubule growth rate [18] and prevents pronuclearmigration
[20].mgr flies, which are mutated in the gene encoding PFDN3,
Table 1. The canonical and prefoldin-like subunit nomenclature. Most
prefoldin subunits have synonymic names. In order to facilitate
comprehension, in this review, we have chosen the main nomenclature of
metazoan prefoldin (PFDN1-6). Likewise, the mammalian prefoldin-like
subunits have been named several times. We call them URI and UXT for
the sake of simplicity.
Archaea S. cerevisiae higher eukaryotes
b Pfd1/Gim6 PFDN1
Pfd2/Gim4 PFDN2
Pfd4/Gim3 PFDN4
Pfd6/Gim1/Yke2 PFDN6/HKE2
a Pfd3/Gim2/Pac10/Rks2 PFDN3/VBP1
Pfd5/Gim5 PFDN5/MM1
Bud27 URI/RMP
UXT/Art-27
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3exhibit circular mitotic figures and loss of meiotic spindle
integrity [19]. In Arabidopsis, PFDN3, PFDN5 and PFDN6 are
required for normal microtubule dynamics and organization
[9,21], whereas the genetic murine models affected in PFDN1
and PFDN5 display developmental defects that were
interpreted in terms of cilia and cytoskeleton defects [22,23].
All these pieces of evidence have shaped the eukaryotic
prefoldin concept as a highly specialized cochaperone for
actin and tubulin folding. This specialization would be con-
sistent with the more severe phenotype of CCT knockdown
than the prefoldin one in C. elegans [18]. However, a more
in-depth review of the scientific literature reveals that eukary-
otic prefoldin has also been connected to phenomena that are
not directly linked to the cytoskeleton, such as protein aggre-
gation. Prefoldin prevents protein aggregation in brain cells
under conditions where protein degradation is compromised
[24]. This role of prefoldin explains its protective effect
against polyglutamine toxicity and the accumulation of aggre-
gated pathogenic huntingtin [25]. Human prefoldin also
inhibits amyloid-b fibrillation and contributes to the formation
of non-toxic amyloid-b aggregates in vitro, which is consistent
with its upregulation in a murine model for Alzheimer’s dis-
ease [26] and the genetic association of prefoldin variants
with this pathology [27].
The involvement of prefoldin subunits in the cytoplasmic
assembly of some non-cytoskeletal complexes has also been
well established. In this case, mammalian PFDN2 and PFDN6
form a complex together with UXT, RPB5, WDR92/Monad,
PDRG1 and URI [28]. In this complex, which is supposed to
adopt a prefoldin-like structure, non-canonical prefoldin pro-
teins substitute for the a subunits and some of the b subunits
(figure 1c), although no evident sequence similarity exists
between canonical and non-canonical prefoldin polypeptides.
The prefoldin-like complex participates in the cytoplasmic
assembly of RNA polymerase II [29], and in the stabilization
and assembly of phosphatidylinositol-3 kinase-related protein
kinase [30]. In both cases, it cooperates with another cochaper-
one, the R2TP complex, which is composed of four subunits:
RVB1, RVB2, PihD1 and hSpagh [31]. The latter two subunits
of R2TP interact with the Hsp90 chaperone, whereas RVB1
and RVB2 are AAAþ ATPases that participate in a set of
additional cellular activities. They act in the context of R2TP,such as in the maturation of small nucleolar ribonucleoprotein
complexes, or independently, contributing to histone acety-
lation, chromatin remodelling, telomere dynamics and mitotic
spindle assembly (for a review, see [32]). Functional analyses
in mammalian cells indicate that the URI subunit of this com-
plex is a target of nutrient signalling and participates in TOR
kinase-controlled gene expression [28]. URI is conserved
through the evolution of eukaryotes, and its yeast homologue
Bud27 also mediates TOR-controlled gene expression [28] and
is involved in the cytoplasmic assembly of all three yeast
nuclear RNA polymerases [33].
a-class prefoldin-like subunit UXT is also located in
human centrosomes, associates with g-tubulin and its over-
expression disrupts the centrosome structure [34]. This
finding indicates that the canonical prefoldin complex may
share some of its cytoskeleton functions with non-canonical
prefoldin subunits.3. Prefoldin shuttles between the
cytoplasm and the nucleus, and acts
on DNA-binding proteins
All the phenomena related to prefoldin that we have examined
so far in this review take place in the cytoplasm.However, both
the canonical and prefoldin-like subunits have also been found
in the nucleus. Proteomic analyses of URI nuclear interactors
indicate that all the components of the R2TP/prefoldin-like
complex, including the canonical prefoldin subunits PFDN2
and PFDN6, are found in the nucleus of prostate cells, and
shuttle between the nucleus and the cytoplasm, probably
together with RNA pol II [35]. The short isoform UXT-V2/
Art-27, of UXT,which has 157 amino acids, is primarily present
in the nucleus, whereas UXT-V1, which encompasses 169
amino acids, is predominantly found in the cytoplasm
[36,37]. This nuclear localization preference of some splice
variants also happens in the case of human PFDN5/MM-1.
MM-1b andMM-1d localize mainly to the cytoplasm, whereas
MM-1a and MM-1g are found in the nucleus [38].
Canonical plant prefoldin, at least its subunits PFDN5
and PFDN6, is also found in the nucleus of Nicotiana
benthamiana and Arabidopsis thaliana leaf cells [39]. Its nuclear
localization is not constitutive, but dependent on the physical
interaction with the nuclear DELLA proteins. Plant prefoldin
moves from the nucleus to the cytosol in response to environ-
mental or endogenous cues that cause degradation of DELLA
proteins [39]. Human PFDN3, also known as von Hippel–
Lindau binding protein1 (VBP1), because of its physical
interaction with VHL, localizes to the cytoplasm when it is
solely expressed, but it translocates to the nucleus when it
is co-expressed with VHL [40]. In turn, VHL localization to
the nucleus depends on UXT [41]. Localization of URI in
the nucleus also depends of its interaction with a partner,
in this case with the DNA methyltransferase 1-associating
protein (DMAP1), which inhibits the cytoplasmic localization
signal of URI and favours its import into the nucleus [42].
In addition to their cytoplasmic localization, all yeast
canonical prefoldin subunits can be detected in the nucleus.
Moreover, they accumulate in the nucleus when the nuclear
export systems based on Xpo1 and Mex67 become genetically
inactivated [43]. So, from yeast to metazoa, prefoldin
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Figure 2. Human PFDN3 favours HIV transcription by driving its integrase
into degradation. HIV integrase remains bound to proviral DNA after its inte-
gration into the host genome. PFDN3 is required for the in situ ubiquitination
of the HIV integrase and its subsequent degradation by the proteasome, by
virtue of its physical interaction with the E3-ubiquitin ligase VHL.
rsob.royalsocietypublishing.org
Open
Biol.4:140085
4subunits are capable of migrating to the nucleus and of being
translocated back to the cytoplasm by active export systems.
Localization of prefoldin in the nucleus may be the result
of the regulation of its cytoplasmic functions by means of a
cytoplasm-exclusion mechanism, as has been demonstrated
in Arabidopsis [39]. In addition to this passive presence of pre-
foldin in the nucleus, several pieces of evidence indicate that
the nucleus is not just a reservoir for stand-by prefoldin. URI,
for instance, is required for DNA stability in C. elegans [44].
A clearer example of a nuclear function of prefoldin is its par-
ticipation in the degradation of the HIV integrase after the
provirus integration into the host genome, which is a strict
requirement for HIV expression [45]. PFDN3 binds the inte-
grase [46] and mediates its interaction with the cullin2-based
VHL ubiquitin ligase, which is essential for its polyubiquitina-
tion and subsequent proteosome-mediated degradation [45]
(figure 2). At least two other prefoldin subunits (PFDN1 and
PFDN6) influence HIV expression at a post-integration step,
suggesting that the whole prefoldin complex acts on the HIV
integrase [45]. PFDN3 also facilitates the VHL-mediated degra-
dation of other well-known DNA-interacting proteins, such as
the DNA mismatch repair protein hMSH4 [47]. In this case,
however, the co-localization of these two proteins is mainly
perinuclear [48].
This nuclear role of mammalian PFDN3 in protein degra-
dation is quite the opposite to that described for Drosophila
PFDN3 in the microtubule dynamics context. In this case,
PFDN3 promotes microtubule stabilization when tubulins
are correctly folded by prefoldin, and tubulin destruction
when they are not [19]. This double role of prefoldin in protein
folding and degradation resembles that of protein segregases
such as the VCP/p97/Cdc48 AAA-ATPase, which segregates
ubiquitinated proteins from stable assemblies with proteins,
membranes and chromatin [49]. Targets of VCP can either
end in degradation, or can survive as free subunits and recycle
[50]. No physical or functional connection between prefoldin
and VCP has been established so far.4. Prefoldin plays transcriptional roles
Among the nuclear proteins bound and influenced by prefol-
din, transcription factors are the most frequent (table 2).
Prefoldin-like subunit UXT binds the EVI1 transcriptional
repressor and suppresses its cell transformation activity [59].
UXT is also an integral component of theNF-kB enhanceosome
and is essential for its nuclear function [60]. Its knockdown
leads to impaired NF-kB activity and dramatically attenua-
tes the expression of NF-kB-dependent genes [60]. UXT is
therefore an optimal target for NF-kB regulation. The
Epstein–Barr virus BGLF4 kinase downregulates NF-kB
transactivation by means of UXT phosphorylation, and the
subsequent interference of this modification with the inter-
action between UXT and NF-kB [61]. Amyotrophic lateral
sclerosis 2 protein has also been suggested to modulate the
NF-kB pathway through its physical interactionwith UXT [62].
UXT is not only involved in NF-kB-dependent transcrip-
tion regulation, but it also contributes to the regulation of
androgen-dependent genes by binding the N-terminal
domain of the androgen receptor (AR) and enhancing its
transcriptional activation [36,63]. UXT also interacts with
LRP16, a macrodomain-containing protein that functions as
a coactivator of AR and other nuclear receptors [64]. Thepositive contribution of UXT- to AR-dependent transactiva-
tion seems to be mediated, at least partially, by the capacity
of UXT to interact with VHL and to facilitate VHL-dependent
ubiquitination of AR [41]. UXT interacts directly with VHL
[41] and without the involvement of PFDN3, indicating that
this ubiquitinating protein can interact with both canonical
and prefoldin-like subunits. Two-hybrid assays suggest that
UXT is also able to interact with the human transcription
factor Sp1 and the TBP-interacting protein TAF130 [36].
A different prefoldin-like subunit, URI, can repress AR-
mediated transcription by interacting physically with UXT
in the chromatin context [35]. URI seems to inhibit AR
recruitment to target genes because it is bound to chromatin
prior to the hormonal activation of AR [35]. URI also inhibits
transactivation by other gene-specific transcription factors,
such as herpes simplex virus transactivator VP16 and hepa-
titis B virus protein X (HBx) [58]. In this case, URI inhibits
HBx-activated transcription by competing with the activator
to bind the RNA polymerase II subunit Rpb5 [58]. The co-
repressor activity of URI is also related to its interaction
with DMAP1, a partner of the histone deacetylase HDAC2
[42]. Interestingly, canonical prefoldin subunit PFDN3 also
influences HBx transcriptional function, yet, in this case, it
cooperates positively with this viral protein in the activation
Table 2. Nuclear proteins that physically interact with canonical or prefoldin-like subunits. For detailed explanations, see the text.
prefoldin subunit interactor (biological process) other factors involved organism reference
PFDN3 HIV integrase VHL human [45]
hMSH4 (DNA repair) VHL, p97 human [47]
NF-kB (transcription) HBx human [51]
PFDN5 c-Myc (transcription) HDAC1–mSin3, TIF1b human [52,53]
Skp2–ElonginB–ElonginC–Cullin2, Rabring7 human [54,55]
EGR1(transcription) human [56]
p73 (transcription) human [57]
PFDN3, PFDN5 DELLA (gene regulation) Arabidopsis thaliana [39]
URI HBx (transcription) Rpb5 human [58]
DMAP1 (transcription) human [42]
UXT EVI1 (transcription) human [59]
NF-kB (transcription) human [60]
HBV EGLF4 kinase (gene regulation) human [61]
ALS2 (gene regulation) human [62]
androgen receptor (transcription) VHL human [36,41,63]
URI human [35]
LRP16 (transcription) human [64]
TAF130 (transcription) human [36]
Sp1 (transcription) human [36]
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5of the NF-kB transcription factor [51]. All these data indicate
considerable plasticity in the ability of the different canonical
and prefoldin-like subunits to interact with transcription fac-
tors, and suggest that they do not necessarily shape a single
functional entity in the nucleus of mammalian cells.
In addition to the degradation of HIV integrase, the
best-characterized contribution of a prefoldin subunit to tran-
scription is the action of PFDN5/MM-1 as a co-repressor of
the E-box-dependent transactivation activity of c-Myc [52].
The MM-1a andMM-1g nuclear isoforms bind the N-proximal
region of c-Myc, which accommodates one of its transactivation
domains, and repress its transcriptional activity [38]. A point
mutation in PFDN5, which is often observed in patients with
leukaemia or lymphoma, abrogates all of its repressive activities
towards c-Myc, indicating that PFDN5 behaves like a tumour
suppressor [65]. The repressive function of PFDN5 is due to
its ability to recruit the histone deacetylase HDAC1–mSin3
complex via transcriptional co-repressor TIF1b. This recruit-
ment antagonizes the histone transacetylases bound to the
N-terminal domain of c-Myc, thereby inhibiting chromatin
remodelling [53] (figure 3a). This inhibitory effect of PFDN5
on c-Myc offers a chance to modulate this transcription factor;
a good example of it is the ability of the hepatitis C virus
ARFP/F protein to enhance the gene transactivation activity of
c-Myc by interfering in its interaction with PFDN5 [66].
The negative action of PFDN5 on the c-Myc function also
takes place at two other levels. It favours c-Myc degradation
by recruiting the ubiquitin ligase Skp2–ElonginC–ElonginB–
Cullin2 complex, and driving it to the proteasome via the 26S
subunit Rpt3 [54] (figure 3b). The monoubiquitination of
PFDN5 by Rabring7, a Rab7-binding and RING finger-
containing protein, stimulates this second role of PFDN5 in
the control of c-Myc [55] (figure 3b). In addition, PFDN5and the Egr-1 repressor bind and downregulate the promoter
of the wnt4 gene. Because the c-Myc gene is the target of
the Wnt–b-catenin pathway, PFDN5 also inhibits the
expression of c-Myc by this indirectmechanism [56] (figure 3c).
The above-described interactions indicate a role of prefol-
din subunits in the regulation of the transactivation capacity
or stability of gene-specific transcription factors. With the
exception of its contribution to HIV expression, the transcrip-
tional roles of prefoldin have been described for single
subunits. Although the presence of other prefoldin subunits
cannot be ruled out, the mechanisms described so far do
not involve the action of prefoldin complexes. Saccharomyces
prefoldin, however, seems to play a transcriptional role that
involves at least the concerted action of PFDN1, PFDN2,
PFDN5 and PFDN6 [43] (figure 4). These four canonical pre-
foldin subunits are recruited together to yeast transcribed
genes in a transcription-dependent manner. The profile of
recruited prefoldin parallels the phosphorylation of the Ser2
residues of Rpb1 CTD, a well-known marker of RNA poly-
merase II elongation activity. Accordingly, the deletion of
any of the genes encoding these four prefoldin subunits pro-
vokes transcription elongation defects [43]. In agreement with
this role of yeast prefoldin in transcription elongation, genes
longer than 4 kpb are particularly affected. The absence of
prefoldin increases the density of histones that remain
bound to these genes under intensive transcription. However,
nucleosome remodelling, reflected in the sensitivity of chro-
matin to micrococcal nuclease digestion, remains unaffected
by the absence of prefoldin. Together, these pieces of evidence
indicate a role of prefoldin in histone eviction after the
cotranscriptional destabilization of nucleosomes [43]. This
prefoldin–chromatin connection is fully consistent with the
strong genetic interactions detected between prefoldin and a
(a)
(b)
(c)
PFDN5
c-Myc
c-MycWnt4
Wnt4
Ub
Ub
Ub
Ub
Ub
Ub CUL-2
proteasome
EloC
EloB
Skp2
Ub
c-Myc c-Myc
Rabring7
PFDN5 PFDN5
PFDN5
Egr1
PFDN5
HDAC1TIF1b
Figure 3. Human PFDN5 is involved in three different control mechanisms of c-Myc. (a) PFDN5 binds the N-terminal region of c-Myc, and represses its transcrip-
tional activity by recruiting the TIF1b correpressor and the histone deacetylase HDAC1–mSin3 complex. (b) PFDN5 drives c-Myc into proteasome-dependent
degradation by recruiting the ubiquitin ligase Skp2–ElonginC–ElonginB–Cullin2 complex. PFDN5 mono-ubiquitination, which is induced by Rabring7, stimulates
this process. (c) PFDN5 and Egr1 cooperate in the transcriptional repression of Wnt4, which is one of the elements of the Wnt-b-catenin pathway that positively
controls the c-Myc gene.
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6wide set of chromatin factors [67,68]. Interestingly, the yeast
CCT mutants display the very same pattern of genetic
interactions with chromatin factors [69]. Moreover, mouse
CCT exhibits a nucleocytoplasmic distribution and associa-
tes to heterochromatin [70], and depletion of Cct2 interferes
with HIV integration at a post-integration step, exactly as
prefoldin does [45]. Taken altogether, the available experimen-
tal evidence suggests that prefoldin and CCT might also
cooperate in the transcriptional dynamics of chromatin.5. Final perspective: prefoldin in global
cell regulation
To date, we have shown that the scientific literature contains a
significant amount of information on the presence of canonical
and prefoldin-like subunits in the nucleus, and their functional
involvement in gene transcription. The examples that we cite
demonstrate that, from yeast to mammals, a given prefoldinsubunit can play cytoplasmic and nuclear roles in the same
organism. Moreover, a set of yeast canonical subunits plays
concerted actions in both cytoplasmic cytoskeleton assembly
and nuclear gene transcription. This fact might merely be
the result of a functional divergence during the evolutionary
transition from archaea to eukaryotes. Alternatively, the cyto-
plasmic and nuclear functions of prefoldin might be coupled
in such a way as to favour a global coordination of gene
expression and cytoskeleton dynamics. This hypothetical
coordination is particularly expected in those situations
where cells are challenged by stimuli that require a specific
genomic response and, at the same time, the reorganization
of cytoplasmic organelles. Although this speculative model is
far from having been demonstrated, there are some experimen-
tal hints that are compatible with the notion of prefoldin as a
global cell regulator.
The cytoskeletal function of prefoldin is not essential for
the housekeeping assembly of microtubules or actin filaments.
This is the reason why yeast prefoldin genes can be deleted
RNApol II
PDF6PDF4PDF1 PDF5
Ser5-P
Ser2-P
prefoldin
Figure 4. Yeast prefoldin stimulates transcription elongation by favouring chromatin dynamics. A subset of canonical prefoldin subunits, including PFDN1, 4, 5 and
6, binds transcribed genes in a transcription-dependent manner and contributes to transcription elongation. This effect is maximal in long genes, where prefoldin
stimulates cotranscriptional histone eviction. Prefoldin binding is absent in the promoter region and is maximal in the 30 end of the gene body to correlate with the
presence of Ser2-hyperphosphorylated RNA polymerase II.
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7without compromising cell viability [8]. Similarly, double
knockout mice, lacking PFDN1, are also viable, at least until
the fifth week of age, although they display a small size and
cytoskeletal defects [22]. When b-tubulin is not expressed at
high levels in Drosophila cells, its stabilization does not require
prefoldin either, although it does when ectopic b-tubulin is
expressed [19]. This indicates that prefoldin is rate-limiting
only under strong cytoskeleton biogenesis conditions. Rate-
limiting steps are the regulatory points in most biological
pathways, and they are usually the most upstream stages.
Accordingly, prefoldin plays its role in the very first step of
microtubules and actin filaments biogenesis [18].
One of the most drastic cytoplasmic reorganizations
takes place during B-lymphocyte activation by antigens,
when they differentiate into highly secretory plasma cells.
PFDN1 knockout mice are severely affected in this process.
Interestingly, the mammalian PFDN6 gene is located in the
centromeric portion of the class II region of the major histo-
compatibility complex [71], and its expression dramatically
increases as a result of lymphocyte activation [72].
So far, the prefoldin role in lymphocyte activation has
not been connected to any nuclear event, but there is one
example where the cytoplasmic function of prefoldin is
linked to the nucleus. This is the case of organ growth by
cell expansion in the model plant Arabidopsis thaliana. The
plant controls anisotropic cell elongation by a mechanism
that finely coordinates the abundance of DELLA proteins
in the nucleus with the subcellular localization of prefoldin
[39]. When environmental conditions are not favourable
for growth, DELLA proteins accumulate, and prefoldin
is retained in the nucleus upon interaction, compromising
its role in the cytoplasm. Thus, microtubule assembly is
compromised, and anisotropic cell growth is prevented.
On the contrary, environmental conditions that are favour-
able for growth promote degradation of DELLA proteins
and prefoldin can move to the cytosol (figure 5) [39].
DELLAs are transcriptional regulators and, although notranscriptional function of prefoldin has been described to
date in Arabidopsis, it is possible that prefoldin participates
not only in the cytoplasmic part of this regulated process,
but also in the transcriptional response.
The coordinated action in cytoskeleton dynamics and
transcription would be facilitated if prefoldin acted on similar
targets in these two processes. It is well known that the
main cytoplasmic targets of prefoldin are actin and tubulin
monomers. It is conceivable that actin, tubulin or both
might also be nuclear targets of prefoldin. The transcriptional
characterization of yeast prefoldin mutants, using chemical
inhibitors of cytoskeleton assembly, indicates that the role
of prefoldin in chromatin dynamics during transcription
elongation is not mediated by actin or tubulin polymerization
[43]. Yet the involvement of actin and tubulin monomers in
the nuclear function of prefoldin is an open possibility.
There is monomeric actin in the nucleus, and its contribution
to gene transcription has already been reported (reviewed
by [73]). The direct involvement of nuclear tubulin in gene tran-
scription has also been described [74]. c-Myc, the best example
of a transcription factor regulated by a prefoldin subunit (see
above), also binds tubulin, and the region of the c-Myc protein
that interacts with tubulin overlaps its PFDN5 interaction
domain [75]. It has been proposed that microtubules might be
involved in the migration of c-Myc to the cytoplasm, when
cells exit the cell cycle [76,77]. Myc-nick, a cleavage product of
c-Myc, promotes tubulin acetylation during cell differentiation
[78], andMIZ-1, another c-Myc-interacting protein, is regulated
by its association to microtubules and activate transcription
in response to cytoskeleton changes [79]. All these data visual-
ize physical and functional interactions between c-Myc and
tubulin, which support functional coupling between c-Myc-
dependent transcription and the cytoskeleton dynamics
mediated by prefoldin.
The existence of such mechanisms of coordination
between cytoplasmic dynamics and genome regulation,
and the potential involvement of prefoldin and other
DELLA
DELLA
CCT
CCT
growth-inducible
conditions
prefoldin
prefoldin
Figure 5. Plant prefoldin collaborates with the DELLA transcription factor in the regulation of cell expansion. When environmental conditions are not favourable for
growth, prefoldin is imported to the nucleus by the DELLA transcription factor, which contributes to the regulation of a set of genes, either positively or negatively.
Upon activation by growth-inducible conditions, DELLA is driven into degradation, allowing prefoldin to relocate to the cytoplasm and to participate in the
cytoskeleton reorganization required for cell expansion.
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8protein-folding factors in them, is a challenging field for
contemporary biology.
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